62484-16-6

基本信息
6-甲基-2,4(1H,3H)-喹唑啉二酮
6-甲基喹唑啉-2,4(1H,3H)-二酮
6-甲基-1,2,3,4-四氫-2,4-喹唑啉二酮
6-Methylquinazoline-2,4-diol
6-methyl-1H-quinazoline-2,4-dione
6-Methyl-1H-quinazoline-2,4-quinone
6-Methyl-2,4(1H,3H)-quinazolinedione
6-Methylquinazoline-2,4(1H,3H)-dione
2,4(1H,3H)-Quinazolinedione, 6-methyl-
6-Methylquinazoline-2,4(1H,3H)-dione,97%
6-Methyl-1,2,3,4-tetrahydro-2,4-quinazolinedione
6-Methyl-1,2,3,4-tetrahydroquinazoline-2,4-dione
物理化學(xué)性質(zhì)
制備方法

590-28-3

2941-78-8

62484-16-6
6-甲基喹唑啉-2,4-二酮的合成:將2-氨基-5-甲基苯甲酸(0.758 g,5 mmol)和氰酸鉀(0.673 g,8.3 mmol)懸浮于水(20 mL)中,隨后加入乙酸(0.5 mL)。反應(yīng)混合物在室溫下攪拌24小時。反應(yīng)完成后,通過真空過濾收集生成的白色固體產(chǎn)物,用水洗滌,并在真空下干燥,得到6-甲基喹唑啉-2,4-二酮(0.736 g,收率84%)。產(chǎn)物的結(jié)構(gòu)通過1H NMR(DMSO-d6)確認:δ 9.90(br s,1H),8.27(d,J = 8.4 Hz,1H),7.70(d,J = 1.8 Hz,1H),7.29(dd,J = 2.4, 8.7 Hz,1H),6.50(br s,1H),2.25(s,3H)。
參考文獻:
[1] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 1, p. 119 - 132
[2] Patent: WO2005/3100, 2005, A2. Location in patent: Page 185
[3] Patent: WO2006/74187, 2006, A2. Location in patent: Page/Page column 49
[4] Patent: WO2008/16666, 2008, A2. Location in patent: Page/Page column 49
[5] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 3, p. 308 - 312